Agilent Technologies Inc. (NYSE: A) today announced the availability of the HYCOR Ultra-Sensitive EIA System for allergen-specific IgE. The HYCOR Ultra-Sensitive EIA System is FDA-cleared for quantitative determination of specific IgE.

Using a unique assay design, the system provides quantitative specific IgE detection with testing capacity sized for moderate to higher-volume labs. Based on proven technology, the system combines quantitative accuracy, precision and sensitivity with fully automated robotics to deliver a new level of performance and productivity, and has been designed to offer laboratories an overall cost-per-test advantage over alternative methods.

“HYCOR has a tradition of providing high-quality allergy testing systems that enable labs to provide physicians with accurate results in a way that is cost effective,” said Skip Thune, HYCOR’s general manager. “The new system has the throughput capacity to allow us to offer the HYCOR cost-effective specific IgE testing solution to larger allergy testing customers that our other systems were too small to properly address. It also sets a new standard for reliable measurement of low levels of specific IgE.”

The new system combines the precision and accuracy of fully automated robotic reagent dispensing with a newly formulated high-sensitivity assay design resulting in superior test performance. A complete menu of clinically important allergens is available with the system and it is QSR, ISO 13485, ISO 9001 and CLSI compliant.

The HYCOR Ultra-Sensitive EIA System expands HYCOR’s portfolio of solutions for allergy testing that already includes the HYTEC 288 Plus. The HYTEC 288 Plus is a fully automated immunoassay system for the performance of allergy and autoimmune antibody testing, and for user-defined ELISA commercial or laboratory developed assays.

The Ultra-Sensitive EIA System is available globally and the menu of assays used with the HYTEC 288 system is compatible with the new system.

To learn more visit HYCOR in booth no. 1149 here at the American Association for Clinical Chemistry Conference or visit www.hycorbiomedical.com.

About HYCOR

HYCOR is a division of Agilent Technologies that manufactures and markets high-quality allergy and autoimmune testing products that are used in clinical laboratories throughout the world. The company is focused on delivering products that provide the highest value to clinicians in terms of innovation, reliability and customer service. HYCOR is also known for its KOVA urinalysis products that help standardize procedures to achieve dependable results and improve safety in both laboratory and point-of-care environments.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.8 billion in fiscal 2008. Information about Agilent is available on the Web at www.agilent.com.